← Open Payments lookup

OMASIEL COMRIE-REINERT: Open Payments

NPI 1649721713 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,034 in 16 payments from 8 companies in 2025. Trend: 2023 $966 · 2024 $2,327 · 2025 $1,034

Food & beverage: $1,034
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.2$250
Neurocrine BioSciences, Inc.2$183
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$148
Supernus Pharmaceuticals, Inc.3$144
E.R. Squibb & Sons, L.L.C.3$107
Boehringer Ingelheim Pharmaceuticals, Inc.1$100
Otsuka America Pharmaceutical, Inc.1$69
ABBVIE INC.1$31

Products named: CAPLYTA, Qelbree, AUSTEDO XR, UZEDY, COBENFY, ABILIFY ASIMTUFII, INGREZZA, VRAYLAR.

Industry payments across PA — which companies pay providers there.